← Nalbuphine

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Nalbuphine

Therapeutic agent (verify pharmacological class)

Prepared 21 Sep 2026

What it is used for

Moderate to severe pain, preoperative and post-operative analgesia, analgesia during labor and delivery. Clinical selection for Nalbuphine should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.

Possible side effects

Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage